1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Critical Therapeutics

Anonymous board for Critical Therapeutics

Sort By:
Title
Replies Views
Last Message ↑
  1. Anonymous
    Replies:
    0
    Views:
    3,212
  2. Anonymous
    Replies:
    15
    Views:
    6,095
  3. Anonymous
    Replies:
    20
    Views:
    6,315
  4. Anonymous
    Replies:
    130
    Views:
    22,165
  5. Anonymous
    Replies:
    0
    Views:
    3,455
  6. Anonymous
    Replies:
    17
    Views:
    12,553
  7. Anonymous
    Replies:
    734
    Views:
    105,219
  8. Anonymous
    Replies:
    1
    Views:
    2,863
  9. Anonymous
    Replies:
    1
    Views:
    4,606
  10. anonymous
    Replies:
    0
    Views:
    2,735

Thread Display Options

Loading...